Katy A M Gaythorpe
Biographic Data
| ID | 7583125 |
|---|---|
| NAME | Katy A M Gaythorpe |
| GIVEN NAMES | Katy A M |
| FAMILY NAME | Gaythorpe |
| SIGNATURE | GAYTHORPE K A M |
| AFFILIATIONS | Imperial College London |
| ORCID | 0000-0003-3734-9081 |
| VERIFIED | Yes |
| TOTAL WORKS | 12 |
| TOTAL CITATIONS | 0 |
| WORKS AS AUTHOR | 12 |
| WORKS AS EDITOR | 0 |
| FIRST PUBLICATION YEAR | 2020 |
| LATEST PUBLICATION YEAR | 2026 |
| H-INDEX | 0 |
Bridging the gap between public health, academia and policy
The use of advanced analytics in public health policy remains hindered by a disconnect between researchers, policymakers and technical experts. Bridging this gap requires intentional knowledge translation strategies that facilitate interdisciplinary collaboration and real-world application of research findings. Hackathons, which bring together diverse stakeholders in a time-bound, solution-oriented format, offer an approach to address this challe…
Timeliness of 24 childhood immunisations and evolution of vaccination delay
Vaccination timeliness is often not considered among standard performance indicators of routine vaccination programmes, such as vaccination coverage, yet quantifying vaccination delay could inform policies to promote in-time vaccination and help design vaccination schedules. Here, we analysed vaccination timeliness for 24 routine childhood immunisations for 54 countries. We extracted individual vaccination status and timing from Demographic and H…
Assessing yellow fever outbreak potential and implications for vaccine strategy
Yellow fever (YF), a vector-borne viral hemorrhagic fever, is endemic in tropical regions of Africa and South America, with large vaccination programmes being used for control. However, significant outbreaks have occurred in recent years. Data on infection rates and seroprevalence is often sparse, requiring robust mathematical models to estimate the burden of yellow fever. In particular, modelling is required to estimate the risk of outbreaks and…
Evaluating the risk of conflict on recent Ebola outbreaks in Guinea and the Democratic Republic of the Congo
Extra vigilance is needed following protests and riot-related conflict events in terms of Ebola virus transmission. These events are highly disruptive, in terms of access to transportation and healthcare and are often in urban areas with high population densities. Additional public health messaging around these types of conflict events, relating to the risks and clinical symptoms may be helpful in reducing transmission. Future work should aim to …
Evaluating effective measles vaccine coverage in the Malaysian population accounting for between-dose correlation and vaccine efficacy
The persistence of measles in Malaysia is due to pockets of insufficient vaccination coverage against measles in the population. Monitoring BdC through immunisation surveillance systems may allow for the identification of susceptible subpopulations (primarily zero-dose MCV individuals) and increase the coverage of individuals who are vaccinated with multiple doses of MCV. This study provides a tool for assessment of national-level population immu…
The impact of social and environmental extremes on cholera time varying reproduction number in Nigeria
Nigeria currently reports the second highest number of cholera cases in Africa, with numerous socioeconomic and environmental risk factors. Less investigated are the role of extreme events, despite recent work showing their potential importance. To address this gap, we used a machine learning approach to understand the risks and thresholds for cholera outbreaks and extreme events, taking into consideration pre-existing vulnerabilities. We estimat…
Reduction in mobility and Covid-19 transmission
In response to the COVID-19 pandemic, countries have sought to control SARS-CoV-2 transmission by restricting population movement through social distancing interventions, thus reducing the number of contacts. Mobility data represent an important proxy measure of social distancing, and here, we characterise the relationship between transmission and mobility for 52 countries around the world. Transmission significantly decreased with the initial re…
How can the public health impact of vaccination be estimated
These methods provide a robust set of approaches to quantify vaccination impact; however it is vital that the area of impact estimation continues to develop in order to capture the full effect of immunisation
Estimating the effects of non-pharmaceutical interventions on Covid-19 in Europe
The impact of Covid-19 and strategies for mitigation and suppression in low- and middle-income countries
Global prospects for COVID-19 control Lower-income countries have recognized the potential impact of coronavirus disease 2019 (COVID-19) from observing ongoing epidemics. Many have intervened quickly and early with measures to slow viral transmission, which may partly explain the low rates observed so far in these countries. Walker et al. calibrated a global model with country-specific data (see the Perspective by Metcalf et al. ). Despite the po…
Estimates of the severity of coronavirus disease 2019
BACKGROUND: In the face of rapidly changing data, a range of case fatality ratio estimates for coronavirus disease 2019 (COVID-19) have been produced that differ substantially in magnitude. We aimed to provide robust estimates, accounting for censoring and ascertainment biases. METHODS: We collected individual-case data for patients who died from COVID-19 in Hubei, mainland China (reported by national and provincial health commissions to Feb 8, 2…
Potential impact of the Covid-19 pandemic on HIV, tuberculosis, and malaria in low-income and middle-income countries
BACKGROUND: COVID-19 has the potential to cause substantial disruptions to health services, due to cases overburdening the health system or response measures limiting usual programmatic activities. We aimed to quantify the extent to which disruptions to services for HIV, tuberculosis, and malaria in low-income and middle-income countries with high burdens of these diseases could lead to additional loss of life over the next 5 years. METHODS: Assu…
No prominent works on this page.
Estimating the effects of non-pharmaceutical interventions on Covid-19 in Europe
The impact of Covid-19 and strategies for mitigation and suppression in low- and middle-income countries
Global prospects for COVID-19 control Lower-income countries have recognized the potential impact of coronavirus disease 2019 (COVID-19) from observing ongoing epidemics. Many have intervened quickly and early with measures to slow viral transmission, which may partly explain the low rates observed so far in these countries. Walker et al. calibrated a global model with country-specific data (see the Perspective by Metcalf et al. ). Despite the po…
Estimates of the severity of coronavirus disease 2019
BACKGROUND: In the face of rapidly changing data, a range of case fatality ratio estimates for coronavirus disease 2019 (COVID-19) have been produced that differ substantially in magnitude. We aimed to provide robust estimates, accounting for censoring and ascertainment biases. METHODS: We collected individual-case data for patients who died from COVID-19 in Hubei, mainland China (reported by national and provincial health commissions to Feb 8, 2…
Potential impact of the Covid-19 pandemic on HIV, tuberculosis, and malaria in low-income and middle-income countries
BACKGROUND: COVID-19 has the potential to cause substantial disruptions to health services, due to cases overburdening the health system or response measures limiting usual programmatic activities. We aimed to quantify the extent to which disruptions to services for HIV, tuberculosis, and malaria in low-income and middle-income countries with high burdens of these diseases could lead to additional loss of life over the next 5 years. METHODS: Assu…
Reduction in mobility and Covid-19 transmission
In response to the COVID-19 pandemic, countries have sought to control SARS-CoV-2 transmission by restricting population movement through social distancing interventions, thus reducing the number of contacts. Mobility data represent an important proxy measure of social distancing, and here, we characterise the relationship between transmission and mobility for 52 countries around the world. Transmission significantly decreased with the initial re…
How can the public health impact of vaccination be estimated
These methods provide a robust set of approaches to quantify vaccination impact; however it is vital that the area of impact estimation continues to develop in order to capture the full effect of immunisation
The impact of social and environmental extremes on cholera time varying reproduction number in Nigeria
Nigeria currently reports the second highest number of cholera cases in Africa, with numerous socioeconomic and environmental risk factors. Less investigated are the role of extreme events, despite recent work showing their potential importance. To address this gap, we used a machine learning approach to understand the risks and thresholds for cholera outbreaks and extreme events, taking into consideration pre-existing vulnerabilities. We estimat…
Evaluating effective measles vaccine coverage in the Malaysian population accounting for between-dose correlation and vaccine efficacy
The persistence of measles in Malaysia is due to pockets of insufficient vaccination coverage against measles in the population. Monitoring BdC through immunisation surveillance systems may allow for the identification of susceptible subpopulations (primarily zero-dose MCV individuals) and increase the coverage of individuals who are vaccinated with multiple doses of MCV. This study provides a tool for assessment of national-level population immu…
Timeliness of 24 childhood immunisations and evolution of vaccination delay
Vaccination timeliness is often not considered among standard performance indicators of routine vaccination programmes, such as vaccination coverage, yet quantifying vaccination delay could inform policies to promote in-time vaccination and help design vaccination schedules. Here, we analysed vaccination timeliness for 24 routine childhood immunisations for 54 countries. We extracted individual vaccination status and timing from Demographic and H…
Assessing yellow fever outbreak potential and implications for vaccine strategy
Yellow fever (YF), a vector-borne viral hemorrhagic fever, is endemic in tropical regions of Africa and South America, with large vaccination programmes being used for control. However, significant outbreaks have occurred in recent years. Data on infection rates and seroprevalence is often sparse, requiring robust mathematical models to estimate the burden of yellow fever. In particular, modelling is required to estimate the risk of outbreaks and…
Evaluating the risk of conflict on recent Ebola outbreaks in Guinea and the Democratic Republic of the Congo
Extra vigilance is needed following protests and riot-related conflict events in terms of Ebola virus transmission. These events are highly disruptive, in terms of access to transportation and healthcare and are often in urban areas with high population densities. Additional public health messaging around these types of conflict events, relating to the risks and clinical symptoms may be helpful in reducing transmission. Future work should aim to …
Bridging the gap between public health, academia and policy
The use of advanced analytics in public health policy remains hindered by a disconnect between researchers, policymakers and technical experts. Bridging this gap requires intentional knowledge translation strategies that facilitate interdisciplinary collaboration and real-world application of research findings. Hackathons, which bring together diverse stakeholders in a time-bound, solution-oriented format, offer an approach to address this challe…
Medicine (12 works) · COVID-19 epidemiological studies (8 works) · Demography (7 works) · Environmental health (7 works) · Computer Science (5 works) · Coronavirus disease 2019 (COVID-19) (5 works) · Outbreak (5 works) · Geography (4 works) · Immunology (4 works) · Infectious disease (medical specialty) (4 works)